522 filings
Page 9 of 27
8-K
PBLA
Panbela Therapeutics, Inc.
8 Jun 22
Submission of Matters to a Vote of Security Holders
5:23pm
10-Q
2022 Q1
PBLA
Panbela Therapeutics, Inc.
Quarterly report
12 May 22
4:10pm
8-K
PBLA
Panbela Therapeutics, Inc.
12 May 22
Panbela Provides Business Update and Reports Q1 2022 Financial Results
4:07pm
UPLOAD
PBLA
Panbela Therapeutics, Inc.
3 May 22
Letter from SEC
12:00am
DEF 14A
PBLA
Panbela Therapeutics, Inc.
Definitive proxy
29 Apr 22
5:04pm
UPLOAD
PBLA
Panbela Therapeutics, Inc.
27 Apr 22
Letter from SEC
12:00am
PRER14A
PBLA
Panbela Therapeutics, Inc.
Preliminary revised proxy
26 Apr 22
5:31pm
CORRESP
PBLA
Panbela Therapeutics, Inc.
26 Apr 22
Correspondence with SEC
12:00am
UPLOAD
PBLA
Panbela Therapeutics, Inc.
21 Apr 22
Letter from SEC
12:00am
PRE 14A
PBLA
Panbela Therapeutics, Inc.
Preliminary proxy
8 Apr 22
5:00pm
EFFECT
PBLA
Panbela Therapeutics, Inc.
29 Mar 22
Notice of effectiveness
12:15am
POS AM
PBLA
Panbela Therapeutics, Inc.
28 Mar 22
Prospectus update (post-effective amendment)
8:46am
S-8
PBLA
Panbela Therapeutics, Inc.
28 Mar 22
Registration of securities for employees
8:45am
10-K
2021 FY
PBLA
Panbela Therapeutics, Inc.
Annual report
24 Mar 22
4:12pm
8-K
PBLA
Panbela Therapeutics, Inc.
24 Mar 22
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
4:06pm
DEFA14A
PBLA
Panbela Therapeutics, Inc.
22 Feb 22
Additional proxy soliciting materials
8:04am
8-K
PBLA
Panbela Therapeutics, Inc.
22 Feb 22
Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
8:03am
SC 13G/A
Michael T. Cullen
14 Feb 22
Panbela Therapeutics / Cullen Michael T. ownership change
5:20pm
8-K
PBLA
Panbela Therapeutics, Inc.
10 Nov 21
Panbela Provides Business Update and Reports Q3 2021 Financial Results
4:16pm
10-Q
2021 Q3
PBLA
Panbela Therapeutics, Inc.
Quarterly report
10 Nov 21
4:10pm